MedPath

Prilocaine

Generic Name
Prilocaine
Brand Names
Agoneaze, Anodyne Lpt, Citanest, Citanest Forte, Dermacinrx Prikaan, Emla, Fortacin, Lido Bdk, Lido-prilo Caine Pack, Lidopril, Oraqix, Prilolid, Prizotral, Relador
Drug Type
Small Molecule
Chemical Formula
C13H20N2O
CAS Number
721-50-6
Unique Ingredient Identifier
046O35D44R

Overview

A local anesthetic that is similar pharmacologically to lidocaine. Currently, it is used most often for infiltration anesthesia in dentistry. (From AMA Drug Evaluations Annual, 1992, p165)

Indication

适用于硬膜外麻醉、阻滞麻醉和浸润麻醉等。

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2025/04/06
Not Applicable
Completed
Istanbul Medeniyet University
2025/03/28
Not Applicable
Completed
Bursa City Hospital
2025/03/28
Not Applicable
Completed
Aynur Aytekin Ozdemir
2024/09/19
Not Applicable
Completed
2024/05/16
Not Applicable
Completed
2024/03/04
Not Applicable
Completed
2024/02/23
Not Applicable
Completed
University Hospital Waterford
2023/12/11
Phase 3
Completed
2023/11/18
Phase 4
Completed
2023/09/05
Phase 4
Withdrawn
Marianne Hutti

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Actavis Pharma, Inc.
0591-2070
TOPICAL
25 mg in 1 g
7/31/2019
Septodont Inc.
0362-9014
SUBCUTANEOUS
40 mg in 1 mL
10/8/2010
Dentsply Pharmaceutical
66312-110
PERIODONTAL
25 mg in 1 g
1/26/2024
Sincerus Florida, LLC
72934-5071
TOPICAL
5 g in 100 g
5/10/2019
Bryant Ranch Prepack
63629-9604
TOPICAL
25 mg in 1 g
11/22/2022
NuCare Pharamceuticals,Inc.
68071-1625
TOPICAL
25 mg in 1 g
1/28/2022
DIRECT RX
61919-443
TOPICAL
25 mg in 1 g
1/20/2020
Dentsply Pharmaceutical Inc.
66312-540
SUBMUCOSAL
40 mg in 1 mL
10/17/2017
Asclemed USA, Inc.
76420-641
TOPICAL
25 mg in 1 g
11/1/2018
Sterling-knight Pharmaceuticals,LLC
69336-825
TOPICAL
25 mg in 1 g
8/16/2016

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
Authorised
11/15/2013

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
RACSER CREAM 5%
SIN14852P
CREAM
2.5%w/w
9/17/2015
TAKIPRIL SOLUTION FOR INJECTION 20MG/ML
SIN16326P
INJECTION, SOLUTION
20.00 mg/ml
9/17/2021
FORTACIN CUTANEOUS SPRAY SOLUTION 7.5MG/dose + 2.5MG/dose
SIN16538P
SPRAY, METERED
2.5mg/dose
7/5/2022
CITANEST OCTAPRESSIN INJECTION
SIN06175P
INJECTION
66 mg/2.2 ml
5/3/1991
EMLA CREAM 5%
SIN06443P
CREAM
25 mg/g
7/2/1991

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

© Copyright 2025. All Rights Reserved by MedPath